search
for
 About Bioline  All Journals  Testimonials  Membership  News


Rwanda Public Health Bulletin
Rwanda Public Health Bulletin
ISSN: 2663-4643
EISSN: 2663-4643
Vol. 1, No. 3, 2019, pp. 11-12
Bioline Code: rp19020
Full paper language: English
Document type: Conference Presentation
Document available free of charge

Rwanda Public Health Bulletin, Vol. 1, No. 3, 2019, pp. 11-12

 en Investing in innovative technology to foster HIV voluntary testing
Hartnett, Bridget; Nakayima, Liliane; Niyingabira, Julien; Habarurema, Gaspard & Kayumba, Malick

Abstract

KEY MESSAGES

Investing in innovative technology to foster HIV voluntary testing is key to achieving the UNAIDS 90-90-90 targets by 2020 which are 90% of people living with HIV will know their HIV status, 90% of people with diagnosed HIV infection will receive antiretroviral treatment, and 90% of people receiving antiretroviral treatment will have viral load suppression.

It is important to invest in youth-driven solutions and community-driven innovations toward ending HIV/AIDS. Placing these populations at the center of the fight address risks and vulnerabilities.

It is important to invest in innovative strategies to fight cervical cancer as a comorbidity of HIV/AIDS.

There is a need to invest in community-based health education to address stigma and discrimination related to HIV/AIDS.

 
© Copyright 2019 - The Author(s)
Alternative site location: https://www.rwandapublichealthbulletin.org

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil